Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Siebenlist

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Current Medicinal Chemistry|April 8, 2003
NF-kappaB activating scaffold proteins as signaling molecules and putative therapeutic targetsAlain Chariot, Marie-Alice Meuwis, Marianne Bonif, et al.
Cellular Signalling|December 22, 2019
Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transitionNitin A Das, Andrea J Carpenter, Anthony Belenchia, et al.
Journal of Neuroinflammation|August 1, 2019
A detrimental role of RelB in mature oligodendrocytes during experimental acute encephalomyelitisAngela S Gupta, Debolina D Biswas, La Shardai N Brown, et al.
Molecular and Cellular Endocrinology|April 5, 2016
TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosisSiva S V P Sakamuri, Anthony J Valente, Jalahalli M Siddesha, et al.
The Journal of Clinical Investigation|October 14, 2006
NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathwayMingzhao Zhu, Robert K Chin, Peter A Christiansen, et al.
European Journal of Immunology|January 24, 2015
The NF-κB regulator Bcl-3 modulates inflammation during contact hypersensitivity reactions in radioresistant cellsIlaria Tassi, Nimisha Rikhi, Estefania Claudio, et al.
Cellular Signalling|October 23, 2012
CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunctionBalachandar Venkatesan, Anthony J Valente, Nitin A Das, et al.
Glia|April 9, 2019
RelB controls adaptive responses of astrocytes during sterile inflammationAngela S Gupta, Michael R Waters, Debolina D Biswas, et al.
Nature Immunology|December 23, 2014
IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cellsYuefeng Huang, Liying Guo, Jin Qiu, et al.
Cellular Signalling|July 23, 2013
TRAF3IP2 mediates interleukin-18-induced cardiac fibroblast migration and differentiationAnthony J Valente, Siva S V P Sakamuri, Jalahalli M Siddesha, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Current Medicinal Chemistry|April 8, 2003
NF-kappaB activating scaffold proteins as signaling molecules and putative therapeutic targetsAlain Chariot, Marie-Alice Meuwis, Marianne Bonif, et al.
Cellular Signalling|December 22, 2019
Empagliflozin reduces high glucose-induced oxidative stress and miR-21-dependent TRAF3IP2 induction and RECK suppression, and inhibits human renal proximal tubular epithelial cell migration and epithelial-to-mesenchymal transitionNitin A Das, Andrea J Carpenter, Anthony Belenchia, et al.
Journal of Neuroinflammation|August 1, 2019
A detrimental role of RelB in mature oligodendrocytes during experimental acute encephalomyelitisAngela S Gupta, Debolina D Biswas, La Shardai N Brown, et al.
Molecular and Cellular Endocrinology|April 5, 2016
TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosisSiva S V P Sakamuri, Anthony J Valente, Jalahalli M Siddesha, et al.
The Journal of Clinical Investigation|October 14, 2006
NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathwayMingzhao Zhu, Robert K Chin, Peter A Christiansen, et al.
European Journal of Immunology|January 24, 2015
The NF-κB regulator Bcl-3 modulates inflammation during contact hypersensitivity reactions in radioresistant cellsIlaria Tassi, Nimisha Rikhi, Estefania Claudio, et al.
Cellular Signalling|October 23, 2012
CIKS (Act1 or TRAF3IP2) mediates high glucose-induced endothelial dysfunctionBalachandar Venkatesan, Anthony J Valente, Nitin A Das, et al.
Glia|April 9, 2019
RelB controls adaptive responses of astrocytes during sterile inflammationAngela S Gupta, Michael R Waters, Debolina D Biswas, et al.
Nature Immunology|December 23, 2014
IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cellsYuefeng Huang, Liying Guo, Jin Qiu, et al.
Cellular Signalling|July 23, 2013
TRAF3IP2 mediates interleukin-18-induced cardiac fibroblast migration and differentiationAnthony J Valente, Siva S V P Sakamuri, Jalahalli M Siddesha, et al.
Pageof 8